{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:41:34Z","timestamp":1759549294074,"version":"build-2065373602"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.2169\/internalmedicine.5113-24","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:15:46Z","timestamp":1742580946000},"page":"2892-2896","source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Hereditary Factor XI Deficiency Accompanied by Lupus Anticoagulant in an Adult Patient with Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.2169","volume":"64","author":[{"given":"Hengwei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Southwest Jiaotong University, The Third People&apos;s Hospital of Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Eby C. Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias. Br J Haematol 145: 151-163, 2009.","DOI":"10.1111\/j.1365-2141.2008.07577.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Coppola A, Tufano A, Di Capua M, et al. Bleeding and thrombosis in multiple myeloma and related plasma cell disorders. Semin Thromb Hemost 37: 929-945, 2011.","DOI":"10.1055\/s-0031-1297372"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bortoli R, Monticielo OA, Chakr RM, et al. Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review. Semin Arthritis Rheum 39: 61-65, 2009.","DOI":"10.1016\/j.semarthrit.2008.03.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Billon S, Blouch MT, Escoffre-Barbe M, et al. A case of chronic myelomonocytic leukaemia and factor XI deficiency with a circulating anticoagulant. Haemophilia 7: 433-436, 2001.","DOI":"10.1111\/j.1365-2516.2001.00523.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemost 39: 621-631, 2013.","DOI":"10.1055\/s-0033-1353420"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shao Y, Cao Y, Lu Y, et al. Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China. Blood Cells Mol Dis 58: 29-34, 2016.","DOI":"10.1016\/j.bcmd.2016.01.004"},{"key":"7","unstructured":"7. Berlin JM, Eisenberg DP, Berlin MB, et al. A randomized, placebo-controlled, double-blind study to evaluate the efficacy of a citrus bioflavanoid blend in the treatment of senile purpura. J Drugs Dermatol 10: 718-722, 2011."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Asselta R, Paraboschi EM, Rimoldi V, et al. Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood 130: e1-e6, 2017.","DOI":"10.1182\/blood-2017-04-780148"},{"key":"9","unstructured":"9. Qu Y, Nie X, Yang Z, et al. The prevalence of hemophilia in mainland China: a systematic review and meta-analysis. Southeast Asian J Trop Med Public Health 45: 455-466, 2014."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lewandowska MD, Connors JM. Factor XI deficiency. Hematol Oncol Clin North Am 35: 1157-1169, 2021.","DOI":"10.1016\/j.hoc.2021.07.012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moellmer SA, Puy C, McCarty OJT. Biology of factor XI. Blood 143: 1445-1454, 2024.","DOI":"10.1182\/blood.2023020719"},{"key":"12","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1055\/a-1683-8605","volume":"5","author":"VA Harris","year":"2021","unstructured":"12. Harris VA, Lin W, Perkins SJ, et al. Analysis of 272 genetic variants in the upgraded interactive FXI web database reveals new insights into FXI deficiency. TH Open 5: e543-e556, 2021.","journal-title":"TH Open","ISSN":"https:\/\/id.crossref.org\/issn\/2512-9465","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhang K, Qin LY, Xu F, et al. The spectrum of factor XI deficiency in Southeast China: four recurrent variants can explain most of the deficiencies. Orphanet J Rare Dis 19: 224, 2024.","DOI":"10.1186\/s13023-024-03235-5"},{"key":"14","unstructured":"14. Wu WM, Ding QL, Wang XF, et al. FXI gene mutations in two pedigrees of congenital clotting factor XI deficiency. Zhonghua Xue Ye Xue Za Zhi 25: 132-135, 2004."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gu\u00e9guen P, Galinat H, Blouch MT, et al. Biological determinants of bleeding in patients with heterozygous factor XI deficiency. Br J Haematol 156: 245-251, 2012.","DOI":"10.1111\/j.1365-2141.2011.08945.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Santoro R, Prejano S, Iannaccaro P. Factor XI deficiency: a description of 34 cases and literature review. Blood Coagul Fibrinolysis 22: 431-435, 2011.","DOI":"10.1097\/MBC.0b013e32834689e4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Riddell A, Abdul-Kadir R, Pollard D, et al. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost 106: 521-527, 2011.","DOI":"10.1160\/TH10-12-0816"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Liu H, Wang HF, Tang L, et al. Genetic analysis in Factor XI deficient patients from central China: identification of one novel and seven recurrent mutations. Gene 561: 101-106, 2015.","DOI":"10.1016\/j.gene.2015.02.021"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 18: 2828-2839, 2020.","DOI":"10.1111\/jth.14846"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bellotti V, Gamba G, Merlini G, et al. Study of three patients with monoclonal gammopathies and &apos;lupus-like&apos; anticoagulant. Br J Haematol 73: 221-227, 1989.","DOI":"10.1111\/j.1365-2141.1989.tb00256.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Murakami H, Irisawa H, Saitoh T, et al. Immunological abnormalities in splenic marginal zone cell lymphoma. Am J Hematol 56: 173-178, 1997.","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<173::AID-AJH7>3.0.CO;2-V"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_5113-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:22:26Z","timestamp":1759548146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_5113-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":21,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5113-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"5113-24"}}